Low population frequencies of autoantibodies associated with anti-phospholipid syndrome (APS) have been reported in literature: For cardiolipin IgM, prevalence generally ranges between 1 and 5%, and for cardiolipin IgG between 1 and 4.2% (29). This evidence concerns the gene CD40LG and antiphospholipid syndrome.